Market Overview

Covidien Announces Continued Relationship with NYSE Euronext

Share:
Related COV
After A Blockbuster 2014, What Will 2015 Hold For Pharmaceutical M&A?
Medtronic CEO: Covidien Merger Has Accelerated Growth Strategy
Related NYX
What a Phone Call from My Aunt Told Me About the Stock Market
Michael Kors to Replace NYSE Euronext in S&P Index on November 12

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that Mallinckrodt plc intends to apply to list its ordinary shares on the New York Stock Exchange (NYSE) to trade under the symbol MNK.

As previously announced, Covidien plans to spin off its Pharmaceuticals business into Mallinckrodt, a stand-alone company, a process expected to be completed in mid-2013.

Posted-In: News

 

Related Articles (COV + NYX)

Around the Web, We're Loving...